Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India
Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique ( Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India )
16 Jul 2026

ASCO 2026: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2026: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
1 Jun 2026

ASCO 2026: Latest in prostate cancer

Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel Merseburger
ASCO 2026: Latest in prostate cancer ( Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel Merseburger )
1 Jun 2026

Early-onset gastrointestinal cancers show more advanced disease and wider racial survival gaps

Dr Jessica Paulus - Ontada, Boston, USA
Early-onset gastrointestinal cancers show more advanced disease and wider racial survival gaps ( Dr Jessica Paulus - Ontada, Boston, USA )
1 Jun 2026

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA
Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer ( Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA )
31 May 2026

ASCO 2026: Latest updates in mRCC

Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke
ASCO 2026: Latest updates in mRCC ( Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke )
30 May 2026

Daraxonrasib plus chemotherapy shows promising first-line activity in RAS-mutant metastatic pancreatic cancer

Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA
Daraxonrasib plus chemotherapy shows promising first-line activity in RAS-mutant metastatic pancreatic cancer ( Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA )
27 Apr 2026

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA
Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )
6 Mar 2026

ESMO 2025: Latest developments in endometrial cancer

Dr Shannon Westin, Dr Brian Slomovitz, Dr Vanda Salutari and Dr Christian Marth
ESMO 2025: Latest developments in endometrial cancer ( Dr Shannon Westin, Dr Brian Slomovitz, Dr Vanda Salutari and Dr Christian Marth )
24 Oct 2025

ESMO 2025: Precision medicine in bladder cancer

Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos
ESMO 2025: Precision medicine in bladder cancer ( Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos )
23 Oct 2025

Tarlatamab plus chemo-IO shows promising efficacy in extensive stage SCLC

Professor Martin Wermke - National Center for Tumor Diseases, Dresden, Germany
Tarlatamab plus chemo-IO shows promising efficacy in extensive stage SCLC ( Professor Martin Wermke - National Center for Tumor Diseases, Dresden, Germany )
23 Oct 2025

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
23 Oct 2025